Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shelly Avramovici-Grisaru is active.

Publication


Featured researches published by Shelly Avramovici-Grisaru.


Journal of The Chemical Society-perkin Transactions 1 | 1995

Iron chelators of the pyridoxal 2-pyridyl hydrazone class. Part 4. pKa Values of the chelators and their relevance to biological properties

Prayong Doungdee; Shalom Sarel; Nipon Wongvisetsirikul; Shelly Avramovici-Grisaru

The proton binding constants (pKa) and species distribution over pH range 1.5–12.0 of two types of biologically active iron chelators (a) pyridoxal type (Lx)—pyridoxal 2-pyridyl hydrazone (PPH) and pyridoxal isonicotinoyl hydrazone (PIH); (b) pyridoxal-betaine type (Ly)—1-[N-methylpyridoxylidenium]-2-[2′-pyridyl] hydrazine iodide (M PH) and 1-[N-ethoxy-carbonylmethylpyridoxylidenium]-2-[2′-pyridyl] hydrazine bromide (EPH) have been determined by glass electrode potentiometry. The lowest pK value in type (a), in the range 2.62 (PPH)–2.45 (PIH) was assigned to pyridinium protonation; the following ionization constants, pKa2= 4.63 (PPH)–4.54 (PIH), to pyridoxylidenium protonation; pKa3= 7.96 (PPH)–7.44 (PIH), to phenolate protonation, and pKa4= 9.96 (PIH)-9.84 (PPH) to amine-hydrazone protonation. At pH 11, in the fully deprotonated forms (Lx2+, and Ly–). At pH ca. 5.0, the pyridoxal-betaines, MPH and EPH, exist predominantly as zwitterions, whereas PPH and PIH are present at that pH predominantly in the neutral, non-zwitterionic, H2Lx form. At higher pH (7.2), PPH and PIH, are present as mixtures of the neutral and the negatively charged monodeprotonated forms (IV).


Journal of Laboratory and Clinical Medicine | 1981

Mechanism of in vivo iron chelation by pyridoxal isonicotinoyl hydrazone and other imino derivatives of pyridoxal

Chaim Hershko; Shelly Avramovici-Grisaru; Gabriela Link; L. Gelfand; S. Sarel


Journal of Medicinal Chemistry | 1983

Syntheses of iron(II) bis(pyridoxal isonicotinoylhydrazone)s and the in vivo iron-removal properties of some pyridoxal derivatives

Shelly Avramovici-Grisaru; Shalom Sarel; G. Link; C. Hershko


Archive | 1988

Pyridoxal hydrazone derivatives their production and use and pharmaceutical compositions containing the same

Shalom Sarel; Shelly Avramovici-Grisaru; Chaim Hershko; Gabriella Link; Dan T. Spira


Journal of Medicinal Chemistry | 1999

Domain-structured N1,N2-derivatized hydrazines as inhibitors of ribonucleoside diphosphate reductase: redox-cycling considerations.

Shalom Sarel; Christian Fizames; François Lavelle; Shelly Avramovici-Grisaru


Free Radical Research | 1991

Fe (Ii)-Chelates Based on Redox-Active Pyridoxal-Betaines as C-Centered Radicals Causing Single- and Double-Strand Scissions to Dna

Eugene N. Iheanacho; Shalom Sarel; Amram Samuni; Shelly Avramovici-Grisaru; Dan T. Spira


Heterocycles | 1998

IRON CHELATORS OF THE CLASS OF PYRIDOXAL ACYLHYDRAZONE. PART 5. CRYSTAL STRUCTURE AND PATTERNS OF HYDROGEN BONDING IN PYRIDOXAL ISONICOTINOYL HYDRAZON E (PIH).

Shalom Sarel; Shmuel Cohen; Shelly Avramovici-Grisaru


Heterocycles | 1990

Synthesis and Crystal Structure of Hydrogen-bonded Long-Chain of 1:1-Methanol:1-[N-Methylpyridoxylidenium]-2-[21-pyridyl]hydrazine Iodide

Shelly Avramovici-Grisaru; Shmuel Cohen; Shalom Sarel


Heterocycles | 1995

Iron Chelators of the Pyridoxal 2-Pyridyl Hydrozone Class. Part III. Ionsation and Conformational Characteristics of the Ligands

Shalom Sarel; Prayong Doungdee; Israel Ringel; Dan Gibson; Nipon Wongvisetsirikul; Shelly Avramovici-Grisaru


Heterocycles | 1998

Iron Chelators of the Pyridoxal-based Class. Part 7. The Synthesis and Single Crystal Structure of 1-(N-Ethoxy-carbonylmethylpyridoxyledenium)-2-(pyrimidyl)hydrazine Salts

Shalom Sarel; Shelly Avramovici-Grisaru; Shmuel Cohen

Collaboration


Dive into the Shelly Avramovici-Grisaru's collaboration.

Top Co-Authors

Avatar

Shalom Sarel

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Chaim Hershko

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Dan T. Spira

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Shmuel Cohen

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Amram Samuni

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Dan Gibson

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Gabriela Link

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Israel Ringel

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

S. Sarel

Shaare Zedek Medical Center

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge